Hi Marin,
I'm wondering if you are interested in feminist legal bioethics (as a pragmatic philosophical approach) or only pure "feminist philosophy" for this issue. Also, am I right to understand from your email that reproductive technologies are not included? What about genetics, race and parentage? is that off the table too?
Hope you are well.
Thanks,
Leslie
Leslie Bender
Professor of Law
Syracuse University College of Law
Syracuse, NY 13244
[log in to unmask]
-----Original Message-----
From: Feminist Approaches to Bioethics on behalf of Marin Gillis
Sent: Thu 5/29/08 3:21 PM
To: [log in to unmask]
Subject: a CFP reminder, apologies for cross-posting
Call for Papers
Special Issue of Hypatia: A Journal of Feminist Philosophy
Medical Biotechnologies, deadline 15 March 2009
Edited by Marin Gillis and Inmaculada de Melo-Martín
Medical biotechnologies have been heralded as both the solution to most problems affecting human beings and their environments, and as a threat to all that matters to us. Feminist analysis of current medical biotechnologies has much to offer to this debate. Hypatia: A Journal of Feminist Philosophy invites submissions that use feminist philosophy to evaluate medical biotechnologies.
Articles exploring feminist philosophical analyses of medical biotechnologies and those evaluating how feminist values might shape the development and implementation of such technologies are welcome. Also of interest are essays reflecting on the gendered, race, and class dimensions of medical biotechnologies, those evaluating the impact of globalization on these biotechnologies and vice-versa, and articles offering new insights into the effects of medical biotechnologies on social and political arrangements.
Although feminist work in biomedicine is frequently assumed to be about women's capacity to procreate, this issue seeks to highlight other dimensions of medical biotechnologies, including human genetic modification, cloning, xenotransplantation, chimeras, pharmacogenomics/genetics, and human genetic databases.
Papers should be no more than 8000 words, inclusive of notes and bibliography, prepared for anonymous review, and accompanied by an abstract of no more than 100 words. Please provide a cover letter identifying your paper as a submission for the special issue "Medical Biotechnologies." The deadline for submissions is 15 March 2009.
Papers should be submitted by electronic attachment in Word to Marin Gillis at [log in to unmask] <mailto:[log in to unmask]> . Submissions should follow Hypatia guidelines (see http://www.msu.edu/~hypatia/ <http://www.msu.edu/~hypatia/> ) Please address all correspondence, questions, and suggestions to Marin Gillis or Inmaculada de Melo-Martín at [log in to unmask] <mailto:[log in to unmask]> .
|